Lung cancer is a serious health issue worldwide, and detecting it early can be tough. One interesting way scientists are tackling this is by looking at something we do every day: breathing. The condensed version of our breath that comes from our lungs and airways can be collected without any invasive procedures. In a study, researchers aimed to find differences in these breath samples between people with non-small cell lung cancer (NSCLC) and those without.

They used a technique called ultra-performance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS) to identify over 30 metabolites, which are small molecules involved in our body's processes. Some of these metabolites, like certain amino acids and fatty acids, were found to be higher in the breath samples of people with NSCLC. Others, like trimethylamine-N-oxide (TMAO), were lower.

To distinguish between NSCLC patients and healthy individuals or those with benign lung conditions, the researchers created a model called OPLS-DA. This model uses a combination of five key metabolites and showed a promising accuracy of 84. 9%, with 86. 2% sensitivity (ability to correctly identify people with NSCLC) and 83. 3% specificity (ability to correctly identify people without NSCLC).

This study highlights a potential non-invasive method for early lung cancer detection, though more research is needed to validate these findings.

Breath Samples as Clues to Lung Cancer

Actions